HESI LPN
Nutrition Final Exam Quizlet
1. What is one benefit of using controls in an experiment?
- A. The size of the groups does not matter.
- B. The subjects are unaware of the experiment's details.
- C. The subjects who are treated are balanced against the placebos.
- D. The subjects are similar in all respects except for the treatment being tested.
Correct answer: D
Rationale: The correct answer is D. Controls in an experiment ensure that the subjects are similar in all respects except for the treatment being tested. This allows for a fair comparison between the treatment group and the control group. Choice A is incorrect because the size of the groups is not the primary benefit of using controls. Choice B is incorrect as blinding, not controls, refers to subjects not knowing about the experiment. Choice C is incorrect as it pertains more to randomization than the use of controls.
2. What is a causative factor of Hirschsprung disease?
- A. Frequent evacuation of solids, liquids, and gases
- B. Excessive peristaltic movement
- C. Absence of parasympathetic ganglion cells in a portion of the colon
- D. One portion of the bowel telescoping into another
Correct answer: C
Rationale: The correct answer is C: Absence of parasympathetic ganglion cells in a portion of the colon. Hirschsprung disease is a congenital condition characterized by the absence of nerve cells (ganglia) in parts of the colon. This absence leads to a lack of peristalsis in the affected segment, resulting in severe constipation and bowel obstruction. Choices A, B, and D are incorrect. Choice A describes symptoms of diarrhea rather than a causative factor of Hirschsprung disease. Excessive peristaltic movement (choice B) is not a causative factor but rather the opposite, as Hirschsprung disease is associated with reduced peristalsis. Choice D, which refers to intussusception, is a different condition unrelated to Hirschsprung disease.
3. How should a healthcare provider address the nutritional needs of a child with chronic kidney disease?
- A. Increase protein intake
- B. Reduce sodium and phosphorus intake
- C. Promote a high-fat diet
- D. Encourage frequent sugary snacks
Correct answer: B
Rationale: Reducing sodium and phosphorus intake is crucial in managing chronic kidney disease in children because it helps prevent complications such as electrolyte imbalances and bone problems. High protein intake can actually be harmful to the kidneys in this condition as it can lead to increased waste production. A high-fat diet is not recommended as it can contribute to heart and blood vessel problems. Encouraging frequent sugary snacks can lead to further complications like obesity and diabetes, which are not beneficial for a child with chronic kidney disease.
4. What will the treatment for a newly admitted child with cystic fibrosis center on?
- A. Chest physiotherapy
- B. Mucus-drying agents
- C. Prevention of diarrhea
- D. Insulin therapy
Correct answer: A
Rationale: The correct answer is A: Chest physiotherapy. Treatment for cystic fibrosis focuses on chest physiotherapy and aerosol medications to manage and clear thick pulmonary secretions. Chest physiotherapy helps loosen and clear mucus from the lungs, aiding in breathing and reducing the risk of infections. Mucus-drying agents (choice B) are not typically used in the treatment of cystic fibrosis as the goal is to help clear mucus, not dry it. Prevention of diarrhea (choice C) is not a primary focus in the treatment of cystic fibrosis. Insulin therapy (choice D) is not relevant to cystic fibrosis, which primarily affects the respiratory and digestive systems.
5. What is the key to preventing recurrent respiratory infections in children with cystic fibrosis?
- A. Routine use of antibiotics
- B. Daily chest physiotherapy
- C. Increased fluid intake
- D. Dietary supplements
Correct answer: B
Rationale: The correct answer is B: Daily chest physiotherapy. Daily chest physiotherapy is essential in cystic fibrosis as it helps in clearing mucus from the lungs, reducing the frequency of respiratory infections. Antibiotics (Choice A) may treat infections but are not the key preventive measure. Increased fluid intake (Choice C) and dietary supplements (Choice D) can be beneficial for overall health but do not directly prevent recurrent respiratory infections in children with cystic fibrosis.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access